Cite Filings / BBIO
Feed Companies Filings Check
Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Filings Insiders Search text
All 834 Financials 137 Shareholder Meetings 10 Executive Compensation 122 Insider Trading 449 Beneficial Ownership Interest 76 Business Combinations 116 Public Offerings 28 Mutual Funds and ETFs 8 Others 133
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-24
  3. DEF 14A Proxy Proxy Statement 2025-04-30
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-04-16
  5. DEF 14A Proxy Proxy Statement 2024-04-25
  6. DEF 14A Proxy Proxy Statement 2023-04-28
  7. DEF 14A Proxy Proxy Statement 2022-04-29
  8. DEF 14A Proxy Proxy Statement 2021-11-08
  9. PRE 14A Proxy Proxy Statement (Preliminary) 2021-10-29
  10. DEF 14A Proxy Proxy Statement 2021-04-30
  11. DEF 14A Proxy Proxy Statement 2020-04-22

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…